3M New Ventures: A venture capital firm focusing on disruptive, early-stage innovations for long-term strategic growth.
Founded
2006
3M Ventures, part of 3M Company, focuses on disruptive, early-stage innovations with long-term strategic relevance. The firm invests across various stages, from seed to Series D, with a particular emphasis on Series A and B rounds. Their investment scope spans multiple industries, aligning with 3M's diverse portfolio and global innovation strategy.
Notable portfolio companies include CelLink, Eko Health, and Metalenz. As a corporate venturing team, 3M Ventures leverages 3M's extensive resources and expertise to help portfolio companies scale efficiently. The firm aims to solve global challenges through partnerships and investments, enhancing 3M's innovation capabilities while supporting promising startups in their growth journey.
3M New Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages